PMD Solutions
← Back to News
Ars TechnicaJun 2, 2026

Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo

Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo

Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.

This news item is fetched from a public RSS feed. Title, summary, and image are © their respective publisher; follow the link above to read the full article on the original site.

Read other topics